Advertisement
Screener

InnovAge Holding Corp. (INNV) Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax

1.9 / 5 stars · 22/57 Roast Me

InnovAge Holding Corp. Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax

InnovAge Holding Corp. (INNV) reported Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax of $266.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-09.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:IncomeLossIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-09-09

  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2026-06-30 was $9.67M.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2026-03-31 was -$29.77M.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2025-12-31 was $12.46M.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for the quarter ending 2025-09-30 was $7.92M.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2026 was $266.00K.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2025 was -$34.03M.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2024 was -$21.82M.
  • InnovAge Holding Corp. income (loss), including portion attributable to noncontrolling interest, before tax for fiscal 2023 was -$50.79M.
Period endIncome (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 3 monthIncome (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 6 monthIncome (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 9 monthIncome (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax 12 month
2026-06-30$9.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09
-$20.11M
derived: sum of 2 quarters · filed 2026-09-09
-$7.65M
derived: sum of 3 quarters · filed 2026-09-09
$266.00K
10-K · filed 2026-09-09
2026-03-31-$29.77M
10-Q · filed 2026-05-08
-$17.32M
derived: sum of 2 quarters · filed 2026-05-08
-$9.40M
10-Q · filed 2026-05-08
-$13.60M
derived: sum of 4 quarters · filed 2026-09-09
2025-12-31$12.46M
10-Q · filed 2026-02-03
$20.37M
10-Q · filed 2026-02-03
$16.17M
derived: sum of 3 quarters · filed 2026-09-09
$5.11M
derived: sum of 4 quarters · filed 2026-09-09
2025-09-30$7.92M
10-Q · filed 2025-11-04
$3.71M
derived: sum of 2 quarters · filed 2026-09-09
-$7.35M
derived: sum of 3 quarters · filed 2026-09-09
-$20.80M
derived: sum of 4 quarters · filed 2026-09-09
2025-06-30-$4.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-09
-$15.26M
derived: sum of 2 quarters · filed 2026-09-09
-$28.72M
derived: sum of 3 quarters · filed 2026-09-09
-$34.03M
10-K · filed 2026-09-09
2025-03-31-$11.06M
10-Q · filed 2026-05-08
-$24.52M
derived: sum of 2 quarters · filed 2026-05-08
-$29.82M
10-Q · filed 2026-05-08
-$30.77M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$13.46M
10-Q · filed 2026-02-03
-$18.76M
10-Q · filed 2026-02-03
-$19.71M
derived: sum of 3 quarters · filed 2026-02-03
-$26.12M
derived: sum of 4 quarters · filed 2026-02-03
2024-09-30-$5.31M
10-Q · filed 2025-11-04
-$6.25M
derived: sum of 2 quarters · filed 2025-11-04
-$12.66M
derived: sum of 3 quarters · filed 2025-11-04
-$16.39M
derived: sum of 4 quarters · filed 2025-11-04
2024-06-30-$946.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-09
-$7.35M
derived: sum of 2 quarters · filed 2025-09-09
-$11.08M
derived: sum of 3 quarters · filed 2025-09-09
-$21.82M
10-K · filed 2025-09-09
2024-03-31-$6.41M
10-Q · filed 2025-05-06
-$10.14M
derived: sum of 2 quarters · filed 2025-05-06
-$20.87M
10-Q · filed 2025-05-06
-$32.36M
derived: sum of 4 quarters · filed 2025-05-06
2023-12-31-$3.73M
10-Q · filed 2025-02-04
-$14.46M
10-Q · filed 2025-02-04
-$25.95M
derived: sum of 3 quarters · filed 2025-02-04
-$34.63M
derived: sum of 4 quarters · filed 2025-02-04
2023-09-30-$10.74M
10-Q · filed 2024-11-05
-$22.23M
derived: sum of 2 quarters · filed 2024-11-05
-$30.90M
derived: sum of 3 quarters · filed 2024-11-05
-$44.36M
derived: sum of 4 quarters · filed 2024-11-05
2023-06-30-$11.49M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-10
-$20.16M
derived: sum of 2 quarters · filed 2024-09-10
-$33.62M
derived: sum of 3 quarters · filed 2024-09-10
-$50.79M
10-K · filed 2024-09-10
2023-03-31-$8.68M
10-Q · filed 2024-05-07
-$22.13M
derived: sum of 2 quarters · filed 2024-05-07
-$39.30M
10-Q · filed 2024-05-07
-$52.19M
derived: sum of 4 quarters · filed 2024-05-07
2022-12-31-$13.46M
10-Q · filed 2024-02-06
-$30.63M
10-Q · filed 2024-02-06
-$43.52M
derived: sum of 3 quarters · filed 2024-02-06
-$50.79M
derived: sum of 4 quarters · filed 2024-02-06
2022-09-30-$17.17M
10-Q · filed 2023-11-07
-$30.06M
derived: sum of 2 quarters · filed 2023-11-07
-$37.33M
derived: sum of 3 quarters · filed 2023-11-07
-$35.03M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$12.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-12
-$20.16M
derived: sum of 2 quarters · filed 2023-09-12
-$17.86M
derived: sum of 3 quarters · filed 2023-09-12
-$7.24M
10-K · filed 2023-09-12
2022-03-31-$7.27M
10-Q · filed 2023-05-09
-$4.97M
derived: sum of 2 quarters · filed 2023-05-09
$5.65M
10-Q · filed 2023-05-09
$16.58M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$2.31M
10-Q · filed 2023-02-07
$12.93M
10-Q · filed 2023-02-07
$23.85M
derived: sum of 3 quarters · filed 2023-02-07
$8.73M
derived: sum of 4 quarters · filed 2023-02-07
2021-09-30$10.62M
10-Q · filed 2022-11-08
$21.55M
derived: sum of 2 quarters · filed 2022-11-08
$6.42M
derived: sum of 3 quarters · filed 2022-11-08
$20.51M
derived: sum of 4 quarters · filed 2022-11-08
2021-06-30$10.93M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-13
-$4.20M
derived: sum of 2 quarters · filed 2022-09-13
$9.89M
derived: sum of 3 quarters · filed 2022-09-13
-$34.97M
10-K · filed 2022-09-13
2021-03-31-$15.13M
10-Q · filed 2022-05-10
-$1.03M
derived: sum of 2 quarters · filed 2022-05-10
-$45.90M
10-Q · filed 2022-05-10
-$29.00M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$14.09M
10-Q · filed 2022-02-09
-$30.77M
10-Q · filed 2022-02-09
-$13.88M
derived: sum of 3 quarters · filed 2022-02-09
-$3.02M
derived: sum of 4 quarters · filed 2022-02-09
2020-09-30-$44.86M
10-Q · filed 2021-11-09
-$27.97M
derived: sum of 2 quarters · filed 2021-11-09
-$17.11M
derived: sum of 3 quarters · filed 2021-11-09
2020-06-30$16.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-23
$27.75M
derived: sum of 2 quarters · filed 2021-09-23
$35.63M
10-K · filed 2021-09-23
2020-03-31$10.86M
10-Q · filed 2021-05-11
$18.74M
10-Q · filed 2021-05-11

Similar stocks

Stock NameCountryMarket CapPE Ratio
Omada Health, Inc. (OMDA)United States$1.207B309.08
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86